Rigosertib for RDEB SCC
Rigosertib for recessive dystrophic epidermolysis bullosa-associated squamous cell carcinoma...
01 May, 2022
Archive
01 April, 2021
Base editing of RDEB fibroblasts
Testing the efficacy of genomic base editing in dystrophic epidermolysis bullosa primary fibroblasts...
01 January, 2021
BrB-101
Development of a topical gene-editing treatment to restore Collagen VII...
01 March, 2019
RNA Derm
Development of IV-administered siRNAs targeting mutant KRT5 and KRT1 in EB Simplex...
01 January, 2018
Gene editing for EB
Gene editing for Epidermolysis Bullosa...
01 May, 2017
EB iPS Consortium
Epidermolysis Bullosa Therapeutic Reprogramming Consortium...
01 December, 2016
Next generation genome editing
Next generation genome editing for Recessive Dystrophic Epidermolysis Bullosa...
01 October, 2015
RDEB SCC gene sequencing
Deep sequencing Recessive Dystrophic Epidermolysis Bullosa squamous cell carcinoma...
01 July, 2015
Lenticol M
Mensenchymal stromal cells engineered to express Collagen VII for the treatment of Recessive Dystrophic Epidermolysis Bullosa...
01 January, 2014
Limbal stem cells
[vc_row css_animation="" row_type="row" use_row_as_full_screen_section="no" type="full_width" angled_section="no" text_align="left" background_image_as_pattern="without_pattern"][vc_column][vc_column_text] Limbal stem cells for treatment of corneal wounds in Epidermolysis Bullosa [ninja_tables id="17851"] Lay summary The cornea, the transparent outer surface of the eye which covers the iris and pupil, is important in bending light that enters the eye into a...